Ellis LM - Search Results

1

CCR 20th Anniversary Commentary: RAS as a Biomarker for EGFR--Targeted Therapy for Colorectal Cancer-From Concept to Practice.

Camp ER, Ellis LM. Camp ER, et al. Among authors: ellis lm. Clin Cancer Res. 2015 Aug 15;21(16):3578-80. doi: 10.1158/1078-0432.CCR-14-2900. Clin Cancer Res. 2015. PMID: 26275951 Free PMC article.

2

Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas.

Kitadai Y, Ellis LM, Takahashi Y, Bucana CD, Anzai H, Tahara E, Fidler IJ. Kitadai Y, et al. Among authors: ellis lm. Clin Cancer Res. 1995 Oct;1(10):1095-102. Clin Cancer Res. 1995. PMID: 9815899

3

Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma.

Kuniyasu H, Ellis LM, Evans DB, Abbruzzese JL, Fenoglio CJ, Bucana CD, Cleary KR, Tahara E, Fidler IJ. Kuniyasu H, et al. Among authors: ellis lm. Clin Cancer Res. 1999 Jan;5(1):25-33. Clin Cancer Res. 1999. PMID: 9918199

4

Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways.

Liu W, Reinmuth N, Stoeltzing O, Parikh AA, Tellez C, Williams S, Jung YD, Fan F, Takeda A, Akagi M, Bar-Eli M, Gallick GE, Ellis LM. Liu W, et al. Among authors: ellis lm. Cancer Res. 2003 Jul 1;63(13):3632-6. Cancer Res. 2003. PMID: 12839952

5

Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor.

Camp ER, Summy J, Bauer TW, Liu W, Gallick GE, Ellis LM. Camp ER, et al. Among authors: ellis lm. Clin Cancer Res. 2005 Jan 1;11(1):397-405. Clin Cancer Res. 2005. PMID: 15671571 Review.

6

Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.

Yang AD, Bauer TW, Camp ER, Somcio R, Liu W, Fan F, Ellis LM. Yang AD, et al. Among authors: ellis lm. Cancer. 2005 Apr 15;103(8):1561-70. doi: 10.1002/cncr.20942. Cancer. 2005. PMID: 15754332 Free article. Review.

7

RON, a tyrosine kinase receptor involved in tumor progression and metastasis.

Camp ER, Liu W, Fan F, Yang A, Somcio R, Ellis LM. Camp ER, et al. Among authors: ellis lm. Ann Surg Oncol. 2005 Apr;12(4):273-81. doi: 10.1245/ASO.2005.08.013. Epub 2005 Mar 15. Ann Surg Oncol. 2005. PMID: 15827676 Review.

8

Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab.

Ellis LM, Curley SA, Grothey A. Ellis LM, et al. J Clin Oncol. 2005 Aug 1;23(22):4853-5. doi: 10.1200/JCO.2005.23.754. J Clin Oncol. 2005. PMID: 16051943 No abstract available.

9

Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.

Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM. Bauer TW, et al. Among authors: ellis lm. Cancer Res. 2005 Sep 1;65(17):7775-81. doi: 10.1158/0008-5472.CAN-05-0946. Cancer Res. 2005. PMID: 16140945

10

Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.

Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W, Somcio R, Bauer TW, Wu Y, Hicklin DJ, Ellis LM. Yang AD, et al. Among authors: ellis lm. Cancer Res. 2006 Jan 1;66(1):46-51. doi: 10.1158/0008-5472.CAN-05-3086. Cancer Res. 2006. PMID: 16397214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters